CAS
NEO icon

CTC Alternative Strategies’s NeoGenomics NEO Stock Holding History

CTC Alternative Strategies’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-13,600
Closed -$63.5K – 57
2015
Q1 		$63.5K Buy
+13,600
New +$59.1K 0.17% 48

Other funds holding NEO

CRC
Curi RMB Capital Chicago, Illinois $6.48B AUM 30.25% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
KIA
Kopp Investment Advisors Bloomington, Minnesota $54.4M AUM 14.33% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

CTC Alternative Strategies's NEO Position: Q2 2015 in Review

CTC Alternative Strategies sold out of NeoGenomics (NEO) in Q2 2015, closing a stake of 13,600 shares — an estimated $63.5K sold.

CTC Alternative Strategies first reported a position in NEO in Q1 2015 and held it in 1 quarter. The position peaked at $63.5K in Q1 2015. 97 funds tracked by Wall St. Rank hold NEO as of Q2 2015.

  • CTC Alternative Strategies reported no remaining NeoGenomics position as of Q2 2015 after selling out during the quarter.
  • CTC Alternative Strategies sold 13,600 NeoGenomics shares in Q2 2015, an estimated $63.5K.
  • CTC Alternative Strategies first reported a position in NeoGenomics in Q1 2015 and held it in 1 quarter.
  • CTC Alternative Strategies's NeoGenomics position peaked at $63.5K in Q1 2015.
  • 97 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2015.

Based on CTC Alternative Strategies's 13F filing for Q2 2015, filed 13 Aug 2015.